| Date | Title | Description |
| 26.07.2026 | Colorado was the first state to cap a drug’s price – then a federal court stepped in (Opinion) | Getting your Trinity Audio player ready...
By Shweta Kumar
Colorado is one of a handful of states with a review board for drug prices and one of only four with a board empowered to set upper limits on what state agencies, insurers and other... |
| 02.04.2026 | Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison | Oral Wegovy demonstrated “significantly greater mean weight loss” than Lilly’s rival pill Foundayo, which was approved this week, Novo Nordisk said Thursday.
Novo’s findings evaluated previously published studies of the medicines and did no... |
| 21.03.2026 | Оземпик на стероидах? В крови питона найден метаболит, подавляющий аппетит без наблюдаемых побочных эффектов... | Скип Маас (справа), аспирант кафедры молекулярной, клеточной биологии, и Лесли Лейнванд, заслуженный профессор кафедры молекулярной, клеточной биологии и биологии развития, наблюдают за двумя питонами Мааса, Гайусом и Агриппиной. Помимо сод... |
| 19.03.2026 | Gousto founder: Rise of weight-loss jabs ‘a depressing state of affairs’ | Gousto founder Timo Boldt is on a mission to make the UK’s food system healthier. But in a world of weight-loss jabs – and after a succession of failed government initiatives – Ali Lyon asks whether he is fighting a losing battle.
What goes... |
| 12.03.2026 | Revisiting the predictions: How have GLP-1s changed the food industry? | Listen to the article 6 min
This audio is auto-generated. Please let us know if you have feedback.
The following is a guest post from Bryan Radtke and Jeremy Bartlow, growth strategy experts at PA Consulting. Opinions are the authors’ own.
... |
| 07.03.2026 | Should drug companies be advertising to consumers? | Getting your Trinity Audio player ready...
By Paula Span, KFF Health News
Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arli... |
| 07.03.2026 | Novo and Hims end feud, will sell obesity drugs together | - |
| 27.02.2026 | Social media can be addictive even for adults, but there are ways to cut back | Getting your Trinity Audio player ready...
By BARBARA ORTUTAY and KAITLYN HUAMANI, AP Technology Writers
Social media addiction has been compared to casinos, opioids and cigarettes.
While there’s some debate among experts about the line bet... |
| 26.02.2026 | More organs are being donated after the heart stops, not brain death. Policies are changing too | Getting your Trinity Audio player ready...
By LAURAN NEERGAARD, Associated Press
WASHINGTON (AP) — The vast majority of organ donations once came from people who were brain-dead. Now they’re increasingly coming from people who died when the... |
| 27.01.2026 | Trump administration announces 15 new drugs for Medicare price negotiation program | Getting your Trinity Audio player ready...
By ALI SWENSON
NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal governme... |
| 23.01.2026 | Gucci to Zara: Brands ramp up fight against domain ‘squatting’ | Global legal disputes over ‘squatted’ web addresses rose to 6,282 cases last year as big companies, especially fashion brands, are fighting back against counterfeit goods.
According to data by Mathys & Squire shared with City AM, disput... |
| 17.01.2026 | Food companies are targeting users of weight-loss drugs with ‘GLP-1 Friendly’ labels | Getting your Trinity Audio player ready...
By DEE-ANN DURBIN
Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like Wegovy and Zep... |
| 25.12.2025 | Oral GLP-1 Revolution: Novo Nordisk Secures First FDA Approval for Obesity Pill | The FDA approved Novo Nordisk's pivotal GLP-1 pill for obesity. This oral treatment, launching early 2026 at $149/month, revolutionizes weight loss access and patient choice. It secures Novo Nordisk a critical first-mover advantage over Eli... |
| 22.12.2025 | FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk | The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk.
Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select telehealth providers with savings offers fo... |
| 17.11.2025 | Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month | Novo Nordisk said it is lowering the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic to $349 per month from $499 per month for existing cash-paying patients.
The company also launched a ... |
| 25.06.2025 | OC&C report outlines impact of Ozempic on the food & beverage sector | OC&C Strategy Consultants has released a new insight into the impact of ‘weight loss’ drugs such as Ozempic on the consumer goods market, with potential ramifications for the local providers.
According to a research survey conducted by ... |
| 24.06.2025 | Slim pickings: grocery sales down as Brits turn to weight-loss jabs | The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away from more than just unhealthy food.
Four per cent of households in the UK now have at least one member using GLP-1, ... |
| 21.06.2025 | Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions | In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly treatment in patients with type 2 diabetes mellitus (T2DM), with significant HbA1c redu... |
| 10.06.2025 | Colorado's Legislative Landscape: A Year of Compromise and Controversy | In the heart of the Rocky Mountains, Colorado's lawmakers have been busy navigating a complex web of climate and social issues. The 2025 legislative session was marked by significant decisions, some celebrated and others criticized. The lan... |
| 05.06.2025 | Easier subscription cancellations, more access to weight-loss drugs among flurry of new Colorado laws | Here’s a look at some of the notable new laws signed this week: Shoring up school meals program
The voter-approved universal school meals program has consistently landed in the red since its launch in 2023. Costs and the program’s popularit... |
| 26.05.2025 | A Double-Edged Sword: The Dangers of Lead in Baby Food and the Promise of Weight-Loss Drugs | In the world of food safety, the stakes are high. Recent events have cast a shadow over baby food products, while new research offers a glimmer of hope for diabetes patients. The juxtaposition of these two stories highlights the complexitie... |
| 22.05.2025 | Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests | “Chronic disease and chronic disease prevention are some of my passions,” said Mavromatis, a former research fellow with an NIH training program.
GLP-1 receptor agonists are injections used to treat diabetes, and some are also approved to t... |
| 13.05.2025 | The Price of Health: Trump’s Bold Move Against Drug Costs | In a bold stroke, President Donald Trump has taken aim at the soaring prices of prescription drugs in the United States. His recent executive order targets weight-loss medications, specifically the popular drugs Wegovy and Zepbound. The goa... |
| 13.05.2025 | Trump calls out weight-loss drugs as target of price-cut push | Trump calls out weight-loss drugs as target of price-cut push
By Deena BeasleyMay 12, 20259:17 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A combination image shows an injection pen of Zepbo... |
| 07.05.2025 | WeightWatchers Files Bankruptcy as GLP-1 Drugs Reshape Market | WeightWatchers, known for its diet programs once endorsed by celebrities including Oprah Winfrey, has filed for bankruptcy after struggling to compete with weight-loss drugs like Ozempic.
The company —which rebranded to WW International Inc... |
| 03.05.2025 | The Cost of Health: GLP-1s and the Future of Employer Healthcare | In the world of healthcare, costs often rise like a tide, relentless and overwhelming. But a new wave is forming, one that promises to reshape the landscape of employer-sponsored health plans. This wave is driven by GLP-1 medications, a cla... |
| 02.05.2025 | Biden wanted Medicaid to pay for weight-loss drugs. Trump just said it doesn’t have to | Medicaid is a joint federal-state funded program that mostly serves people with lower incomes under the age of 65 or who have a disability. The federal Medicare program focuses primarily on people above the age of 65, no matter their income... |
| 30.04.2025 | GLP-1s can help employers lower medical costs in 2 years, new study finds | Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs.
Aon looked at medical claims data for 139,000 U.S.-based workers with employer heal... |
| 07.04.2025 | The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution | Some bills have stalled while others remain alive, including a proposal in Arkansas requiring GLP-1s to be covered under Medicaid when prescribed specifically for weight loss. Iowa lawmakers are thinking about ordering a cost-benefit analys... |
| 17.03.2025 | AI Innovator NotCo Teases GLP-1 Booster That Acts As ‘Natural Alternative’ to Ozempic | 4 Mins Read Always at the forefront of food trends, Chilean food tech startup NotCo has unveiled a GLP Booster that uses food as a natural Ozempic alternative.
Today, nearly three-quarters of Americans aged 20 and above are overweight and o... |
| 31.01.2025 | The Crossroads of Health and Politics: A Look at Current American Debates | In the landscape of American politics, health issues often become battlegrounds. The recent discussions surrounding vaccines, food safety, and gender-affirming care reveal deep divides and shared concerns among the populace. As the nation g... |
| 29.01.2025 | National Politics | What US adults think of Robert F. Kennedy Jr. and his views on vaccines, fluoride and raw milk | More oppose than support reevaluating widely used vaccines
Kennedy has long been a vaccine skeptic, and he and Trump have falsely claimed that childhood vaccines are dangerous and tied to rising autism rates. His opposition to vaccines is b... |
| 07.01.2025 | Americans Using GLP-1 Drugs Are Spending Less on Groceries & UPFs | 4 Mins Read US households with at least one user of GLP-1 drugs like Ozempic are spending 6-9% less on groceries, with the sharpest declines seen in ultra-processed categories.
For Ozempic users, chips, baked goods, calories, and grocery bi... |
| 07.01.2025 | Plant-Rich Diets Best for Microbiome Health, Shows Study by UK Gut Guru | 5 Mins Read Tim Spector’s health app Zoe analysed poop samples from over 21,000 people to find the best diet for the gut microbiome.
With gut health and GLP-1 drugs top of mind for many consumers in 2025, food and drink manufacturers are wo... |
| 02.01.2025 | How Microplastics Damage the Gut Microbiome & Raise the Risk of Chronic Diseases | 4 Mins Read Researchers in India highlight how microplastics harm the human gut microbiome, and subsequently our overall health.
From takeaway coffee cups and washing machines to sea salt and tap water, microplastics are omnipresent in the ... |
| 18.12.2024 | Nestlé launches drink that suppresses hunger, promotes GLP-1 production | Listen to the article 3 min
This audio is auto-generated. Please let us know if you have feedback. Dive Brief:
Nestlé’s Boost brand launched a pre-meal drink to help consumers suppress their hunger and create a feeling of being full. The pr... |
| 12.12.2024 | Health | Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids? | Dr. Chris Straughn, a pediatrician at Medical City Children’s Hospital in Dallas, said research shows GLP-1s can be both effective and safe for kids and teens, but that research only shows the impact over a few years.
“Both in kids and adul... |
| 04.12.2024 | LifeSpeak Inc. Expands Weight Management Libraries and Wellbeing Solutions with New GLP-1 Resources to Help Employers and Health Plans Maximize Their Investment in GLP-1s | LifeSpeak Inc. expands weight management solutions with new GLP-1 resources. Photo courtesy of LifeSpeak Inc.
New expert content from Wellbeats Wellness and LifeSpeak Mental Health & Resilience complements GLP-1 coverage strategies for ... |
| 29.11.2024 | Navigating Holiday Health: SANE MD's Natural Solutions for Weight Management and Respiratory Comfort | The holiday season is a double-edged sword. It brings joy, celebration, and indulgence, but it also poses challenges to our health. With rich foods and seasonal viruses lurking, maintaining wellness can feel like walking a tightrope. Fortun... |
| 29.11.2024 | Amazon Cyber Monday 2024: Viscera-3 with Sodium Butyrate The Natural Ozempic Alternative for Holiday Weight Management | This Amazon Cyber Monday, SANE MD offers Viscera-3® with sodium butyrate a natural, science-backed way to support weight management and digestive health during the holidays. Available now on Amazon, Viscera-3® provides a convenient, holisti... |
| 13.11.2024 | Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder | Obesity-fighting drugs may reduce alcohol consumption in individuals with alcohol use disorder
Wed, Nov 13, 2024 17:00 CET Report this content
A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found ... |
| 12.11.2024 | New Guidelines and Investments: A Dual Approach to Combat Health Threats | Stroke is a silent predator. It strikes swiftly, often without warning. The latest guidelines from health authorities aim to arm the public with knowledge and tools to fend off this fourth leading cause of death in the United States. Meanwh... |
| 12.11.2024 | The Unsung Heroes of Cleanliness: Janitors in Office Spaces | Janitors are the backbone of cleanliness in office environments. They work tirelessly behind the scenes, ensuring that spaces are not just clean but also welcoming. Yet, their challenges are often invisible to the eye. This article explores... |
| 11.11.2024 | Health | Here are new guidelines for preventing stroke, the nation’s 4th biggest killer | Here’s what to know about stroke and the new guidelines:What is a stroke?
A stroke happens when blood flow to part of the brain is blocked or if a blood vessel in the brain bursts. That deprives the brain of oxygen which can cause brain dam... |
| 04.11.2024 | Is your business about to feel the Ozempic squeeze? | - |
| 04.11.2024 | Smoothie King Taps Into a Major Health Trend With Its 'GLP-1 Support Menu' As GLP-1 medications gain popularity for weight management, this menu aims to fit users' unique dietary needs. | Smoothie King, the world's largest smoothie brand, is venturing into new territory with the launch of its "GLP-1 Support Menu," designed for individuals using GLP-1 agonists in their weight loss or management programs. As these me... |
| 24.10.2024 | EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs | PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announce today that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the Office of Generic Dr... |
| 17.10.2024 | Gan & Lee Pharmaceuticals: A New Dawn in Diabetes Treatment | In the world of diabetes management, innovation is the lifeblood. Gan & Lee Pharmaceuticals is injecting new hope into this arena with three groundbreaking drugs: GZR18, GZR4, and GZR101. These investigational drugs have shown promising... |
| 16.10.2024 | Mintel Announces Global Food and Drink Trends for 2025 | SINGAPORE, Oct. 16, 2024 /PRNewswire/ -- Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see more f... |
| 15.10.2024 | Gan & Lee Pharmaceuticals' Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies | After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®).
After 16 weeks of treatment in... |
| 16.09.2024 | «Оземпик» превратили в гидрогель.Его не надо колоть еженедельно, а достаточно нанести раз в месяц | Исследователи из Франции разработали систему введения семаглутида один раз в месяц на основе гидрогеля, что значительно упрощает лечение диабета и контроль веса. Она будет представлена на ежегодном собрании Европейской ассоциации по изучени... |
| 14.08.2024 | SoWell Launches The First and Only Supplement System for GLP-1 Users to Thrive on the Medication | NEW YORK, Aug. 14, 2024 /PRNewswire/ -- SoWell is proud to announce the launch of the only three-part supplement system designed specifically for GLP-1 users and their side effects: the SoWell GLP-1 Support System ($104.99). Dr. Alexandra S... |
| 27.07.2024 | Найден новый способ лечения ожирения. У него даже нет побочных эффектов | Исследование выявило критическую роль гена SH2B1 в развитии ожирения через его влияние на функции мозга и регуляцию энергии, что открывает многообещающий терапевтический потенциал для лечения ожирения без побочных эффектов современных лекар... |
| 16.07.2024 | Health | Taking Ozempic or other weight-loss meds? Watch your diet to avoid ‘exchanging one problem for another’ | Jennifer Kirtley, of Lake Worth Beach, started using weight-loss medication Wegovy in early April and has so far lost 38 pounds. (Carline Jean/South Florida Sun Sentinel)The side effects are challenging
Ten GLP-1 drugs, including a class of... |
| 12.07.2024 | Названы способы уменьшить вероятность смерти от рака: «Никогда не поздно» | “Это те вещи, с помощью которых люди могут практически изменить свой образ жизни каждый божий день, чтобы снизить риск развития рака”, - сказал доктор Ариф Камаль, главный специалист по работе с пациентами Американского онкологического обще... |
| 10.07.2024 | Health | Mounjaro bests Ozempic for weight loss in first head-to-head comparison of real-world use | The findings were published Monday in JAMA Internal Medicine.
Dr. Matthew Freeby, an endocrinologist and director of the Gonda Diabetes Center at UCLA’s Geffen School of Medicine, said the study results are in line with what he has observed... |
| 05.07.2024 | Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows | LONDON: Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published o... |
| 11.06.2024 | The Vitamin Shoppe Unveils its Top Five Health and Wellness Trends for 2024 in Exclusive Study | Proprietary sales data and a new consumer survey from the national health and wellness retailer reveal the latest trends, products, and shopping behaviors that are shaping the nutritional supplements market
SECAUCUS, N.J., June 11, 2024 /PR... |
| 04.06.2024 | Horizon Media's Study "Injecting Change: Weighing the Future of Insurance in the Age of Ozempic" Gives a Prescription to Health Insurance Companies | Horizon Media
Horizon Media, the largest U.S. media agency according to Ad Age Data Center 2023, today unveiled "Injecting Change: Weighing the Future of Insurance in the Age of Ozempic," a study of the challenges the growing popu... |
| 28.05.2024 | The High Cost of Diabetes Drugs: A Barrier to Health | In the realm of healthcare, the issue of affordability and access to essential medications is a critical concern that affects the well-being of individuals, particularly those suffering from chronic conditions like diabetes. The soaring pri... |
| 25.05.2024 | Health | High price of popular diabetes drugs deprives low-income people of effective treatment | Supply shortages and insurance hurdles for this powerful class of drugs, called GLP-1 agonists, have left many people who are suffering from diabetes and obesity without the medicines they need to stay healthy.
One root of the problem is th... |
| 22.05.2024 | Health | Hims & Hers to sell inexpensive Ozempic alternative | Regulators recommended in January that pharmaceutical customers “should not use a compounded drug if an approved drug is available to treat a patient.”
Hims & Hers CEO Andrew Dudum told CNBC the company is working with one of the nation... |
| 21.05.2024 | Diabetes, heart problems and kidney disease are closely linked: What to know about their shared risk factors | Heart disease, diabetes and kidney disease are among the most common chronic illnesses in the United States – and they’re all closely connected.
Adults with diabetes are twice as likely to have heart disease or a stroke compared with those ... |
| 21.05.2024 | Nestlé debuts new brand for consumers using GLP-1 drugs, managing weight | Listen to the article 6 min
This audio is auto-generated. Please let us know if you have feedback.
Nestlé is launching its first major U.S. brand in nearly three decades as the food giant looks to meet the needs of consumers taking GLP-1 me... |
| 29.04.2024 | Supergut Quadruples Sales & Expands Retail Presence with Nationwide GNC Deals | 5 Mins Read Supergut, an emerging leader in the GLP-1 food space, is rolling out its superfood products at breakneck speed in US retail, after quadrupling sales over the last six months.
Your Erewhon smoothie could now help you control your... |
| 26.04.2024 | Sponsored Content | PlushCare Reviews – Is It Legit or Not Worth the Money? (High-Quality Virtual Primary Care) | In a world where obesity rates are steadily climbing and the quest for effective weight loss solutions remains an ever-present challenge, PlushCare emerges as a beaming hope, offering a comprehensive weight loss program led by board-certifi... |
| 26.04.2024 | Health | TikTok to crack down on content that promotes disordered eating and dangerous weight-loss habits | Andrea Chang | (TNS) Los Angeles Times
Saying it does not want to promote negative body comparisons, TikTok is cracking down on posts about disordered eating, dangerous weight-loss habits and potentially harmful weight-management products.
... |
| 19.04.2024 | Do You Want to Live to Be 100? This Researcher Has the Answer to Why Longevity is Not a Quick Fix or Trendy Diet Ozempic, cold plunges, sobriety and the latest health fads are not what science reveals... | - |
| 09.04.2024 | How the 'Oh-oh-oh Ozempic' commercial song made a musician $1 million | Media How the 'Oh-oh-oh Ozempic' commercial song made a musician $1 million
Peter Kafka
2024-04-09T20:05:43Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It indicates the abil... |
| 06.04.2024 | Fashion designer finds rewarding career as chef cooking up "big, happy, colorful" meals | More than 70% of Americans say a rewarding career or job is extremely important for them to live a fulfilling life — more important than family, friends or wealth. CBS News interviewed a broad array of workers who chose unique jobs, for a s... |
| 19.03.2024 | Ozempic Maker Novo Nordisk to Upgrade China Insulin Plant for USD555.6 Million | (Yicai) March 19 -- Novo Nordisk, a major global producer of insulin and weight loss drugs, will invest CNY4 billion (USD555.6 million) to revamp its plant in northern China’s Tianjin to meet local demand for innovative drugs.
The pharmaceu... |
| 16.02.2024 | Kelly Osbourne defends using Ozempic for weight loss: 'I think it's amazing' | Entertainment Kelly Osbourne defends using Ozempic for weight loss: 'I think it's amazing'
Olivia Singh
2024-02-16T16:03:01Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An envelope. It in... |
| 12.02.2024 | Addressing Misinformation | (BPT) - Frequently asked questions about Ozempic (semaglutide)
Novo Nordisk is a healthcare company with a 100-year history of driving change to improve the lives of people living with serious, chronic diseases. As broader conversations ab... |
| 21.01.2024 | How Ozempic, other weight-loss drugs are "changing medicine" | Forty-four-year-old LaQuita Clark says memories of being overweight – and ridiculed – go back to middle school. "I remember sitting on the school steps with a group of my friends, and just a group of other kids walking by: 'Oh my God, ... |
| 09.01.2024 | How Ozempic changed my mind, body – and investment strategy | Bharat Vasan is a partner and COO at The Production Board, a San Francisco-based venture capital firm and business foundry. Vasan has more than 20 years of experience at early-stage technology businesses and Fortune 100 companies. Reach him... |
| 03.01.2024 | Health | Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024 | Weight loss has been one of the most talked about topics of 2023 and it’s certain to heat up even more in the new year.
Florida is now blanketed with med spas, weight management clinics, and online pharmacies that sell Ozempic, Wegovy and d... |
| 20.03.2023 | Americans desperate for the hot weight-loss drug Ozempic are turning to Canada and Mexico because they can't afford it at home | Redeem now
Demand for prescription drugs that help with weight loss, such as Ozempic and Wegovy, is surging.
But the drugs' high cost and a lack of insurance coverage means they're are out of reach for many.
Some people in the US have start... |
| 18.11.2022 | A woman lost 30 pounds in four months on a 'game changer' weight loss drug, but now 'can't stand' Diet Coke and feels full after two alcoholic drinks | Health A woman lost 30 pounds in four months on a 'game changer' weight loss drug, but now 'can't stand' Diet Coke and feels full after two alcoholic drinks
Catherine Schuster-Bruce
2022-11-18T12:06:37Z
Share icon An curved arrow pointing r... |
| - | People should stop taking Ozempic, Wegovy obesity drugs before surgery, doctors group says | People on diabetes and weight loss drugs such as Ozempic and Wegovy should stop taking them before elective surgery to reduce the risk of serious complications, a prominent doctors group said.
The group has received anecdotal reports from a... |
| - | Ozempic maker Novo Nordisk surges past Tesla with market value of $566B | Novo Nordisk on Thursday surpassed Tesla in market valuation after the maker of the popular weight-loss drug Wegovy and Ozempic announced positive early trial data for a highly anticipated new obesity drug.
Shares surged more than 8% to rec... |
